News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Piet Ost: Can Durvalumab and SBRT improve outcomes in Oligorecurrent Prostate Cancer?
Piet Ost/X
May 4, 2025, 10:21

Piet Ost: Can Durvalumab and SBRT improve outcomes in Oligorecurrent Prostate Cancer?

Piet Ost, Radiation Oncologist at Iridium Network Antwerp, shared a post on X:

“POSTCARD trial by Dr Supiot: Can durvalumab and SBRT improve outcomes in oligorecurrent Prostate Cancer?

  • No PFS benefit at 2 years vs SBRT alone.
  • Deeper PSA responses in some patients.
  • CTC count <5 linked to better outcomes.”

Piet Ost: Can Durvalumab and SBRT improve outcomes in Oligorecurrent Prostate Cancer?

More posts featuring Piet Ost.

cancer Durvalumab ESTRO25 fight against cancer Global fight against cancer Iridium Network Antwerp Oligorecurrent Prostate Cancer OncoDaily Oncology Piet Ost POSTCARD trial prostate cancer SBRT
Special Coverage
Blog
May 4, 2025, 12:33
Giulio Francolini: QoL data from DART trial
Science
May 4, 2025, 12:21
Breast Cancer in Young patients at ESTRO 2025: The Impact of BRCA-carriership on indications for RT
Science
May 4, 2025, 11:47
Breast Cancer in Young patients at ESTRO 2025: Reproductive issues in young BRCA carriers affected by breast cancer
Insight
May 4, 2025, 11:45
Sergio Cifuentes highlights key limitations of the PLATFORM study on esophagogastric adenocarcinoma
Insight
May 4, 2025, 11:29
STELLAR II trial at ESTRO 2025: Immunotherapy Combined with Radiotherapy and Chemotherapy Reduces the Need for Surgery in Locally Advanced Rectal Cancer
Blog
May 4, 2025, 11:26
Collaboration between National Societies and Patients can Strengthen Advocacy - ESTRO
Blog
May 4, 2025, 11:14
Marie-Catherine Vozenin Honored with Claudius Regaud Award at ESTRO 2025
Blog
May 4, 2025, 11:13
Princess Dina Mired: A true trailblazer in Pediatric Oncology by Carlos Rodriguez-Galindo
Blog
May 4, 2025, 11:11
Ina Jürgenliemk-Schulz Receives Iridium 192 Award at ESTRO 2025
Societies
May 4, 2025, 11:03
ASCO Urges Lawmakers to Protect Federal Funding for Cancer Research and Prevention
Blog
May 4, 2025, 10:59
Sarah Barrett: A great and busy start to ESTRO25
Blog
May 4, 2025, 10:57
Joanna Metzner-Sadurski: Proud of Ruiling Yuan for Moderating 2025 COP Webinar on Oncology Advocacy